Miranda Lomer

11.3k total citations · 2 hit papers
127 papers, 6.5k citations indexed

About

Miranda Lomer is a scholar working on Gastroenterology, Genetics and Epidemiology. According to data from OpenAlex, Miranda Lomer has authored 127 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Gastroenterology, 56 papers in Genetics and 36 papers in Epidemiology. Recurrent topics in Miranda Lomer's work include Gastrointestinal motility and disorders (57 papers), Inflammatory Bowel Disease (35 papers) and Diet and metabolism studies (24 papers). Miranda Lomer is often cited by papers focused on Gastrointestinal motility and disorders (57 papers), Inflammatory Bowel Disease (35 papers) and Diet and metabolism studies (24 papers). Miranda Lomer collaborates with scholars based in United Kingdom, United States and Australia. Miranda Lomer's co-authors include Kevin Whelan, Peter M. Irving, Heidi M. Staudacher, Jonathan J. Powell, R. P. H. Thompson, Jeremy Sanderson, Gareth Parkes, James O. Lindsay, Lee Martin and Susan Shepherd and has published in prestigious journals such as Gastroenterology, PLoS ONE and American Journal of Clinical Nutrition.

In The Last Decade

Miranda Lomer

120 papers receiving 6.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Fermentable Carbohydrate Restriction Reduces Luminal Bifidobacteria and Gastrointestinal Symptoms in Patients with Irritable Bowel Syndrome

2012 435 citations Heidi M. Staudacher, Miranda Lomer et al. Journal of Nutrition profile →
Effects of Low FODMAP Diet on Symptoms, Fecal Microbiome, and Markers of Inflammation in Patients With Quiescent Inflammatory Bowel Disease in a Randomized Trial

2019 252 citations James O. Lindsay, Miranda Lomer et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Miranda Lomer United Kingdom	45	3.2k	2.1k	1.9k	1.5k	1.1k	127	6.5k
Jane G. Muir Australia	51	5.6k 1.7×	2.0k 0.9×	3.6k 1.9×	2.3k 1.5×	1.3k 1.2×	145	10.9k
Peter R. Gibson Australia	52	4.6k 1.4×	3.9k 1.8×	1.7k 0.9×	3.0k 1.9×	3.7k 3.2×	205	10.6k
Kevin Whelan United Kingdom	61	5.1k 1.6×	2.9k 1.4×	3.9k 2.1×	2.8k 1.8×	1.5k 1.3×	290	13.6k
Susan Shepherd Australia	34	3.9k 1.2×	1.5k 0.7×	1.9k 1.0×	1.5k 1.0×	1.1k 0.9×	76	6.3k
Lawrence R. Schiller United States	40	3.5k 1.1×	647 0.3×	1.0k 0.5×	2.4k 1.6×	1.0k 0.9×	106	6.8k
Henry J. Binder United States	55	1.5k 0.5×	1.0k 0.5×	1.0k 0.5×	2.2k 1.4×	906 0.8×	209	9.4k
Michael D. Levitt United States	37	1.1k 0.3×	962 0.5×	1.5k 0.8×	1.3k 0.8×	250 0.2×	107	4.8k
Benoît Coffin France	43	2.5k 0.8×	763 0.4×	1.1k 0.6×	2.6k 1.7×	802 0.7×	177	5.4k
Peter J. Milla United Kingdom	44	2.2k 0.7×	714 0.3×	565 0.3×	2.8k 1.8×	554 0.5×	191	6.5k
A M Dawson United Kingdom	43	1.1k 0.3×	1.4k 0.6×	755 0.4×	1.7k 1.1×	1.9k 1.7×	136	5.8k

Countries citing papers authored by Miranda Lomer

Since Specialization

Citations

This map shows the geographic impact of Miranda Lomer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miranda Lomer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miranda Lomer more than expected).

Fields of papers citing papers by Miranda Lomer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miranda Lomer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miranda Lomer. The network helps show where Miranda Lomer may publish in the future.

Co-authorship network of co-authors of Miranda Lomer

This figure shows the co-authorship network connecting the top 25 collaborators of Miranda Lomer. A scholar is included among the top collaborators of Miranda Lomer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miranda Lomer. Miranda Lomer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dimidi, Eirini, Kevin Barrett, Adam D. Farmer, et al.. (2025). Evidence-based guidelines for the dietary management of chronic constipation in adults: systematic reviews of randomised controlled trials, GRADE approach and Delphi expert consensus. Proceedings of The Nutrition Society. 84(OCE3). 1 indexed citations

Dimidi, Eirini, Kevin Barrett, Adam D. Farmer, et al.. (2025). British Dietetic Association Guidelines for the Dietary Management of Chronic Constipation in Adults. Journal of Human Nutrition and Dietetics. 38(5). e70133–e70133.

Belogianni, Katerina, et al.. (2024). Exploring Dietitians’ Perspectives Toward Current Practices and Services in Relation to Irritable Bowel Syndrome Management in Clinical Settings Across the United Kingdom: A Qualitative Study. Journal of the Academy of Nutrition and Dietetics. 125(3). 335–347.

Wall, Catherine, Bridgette Wilson, & Miranda Lomer. (2023). Development and validation of an inflammatory bowel disease nutrition self-screening tool (IBD-NST) for digital use. Frontiers in Nutrition. 10. 1065592–1065592. 6 indexed citations

Dimidi, Eirini, Katerina Belogianni, Kevin Whelan, & Miranda Lomer. (2023). Gut Symptoms during FODMAP Restriction and Symptom Response to Food Challenges during FODMAP Reintroduction: A Real-World Evaluation in 21,462 Participants Using a Mobile Application. Nutrients. 15(12). 2683–2683. 11 indexed citations

Lomer, Miranda, Bridgette Wilson, & Catherine Wall. (2022). British Dietetic Association consensus guidelines on the nutritional assessment and dietary management of patients with inflammatory bowel disease. Journal of Human Nutrition and Dietetics. 36(1). 336–377. 38 indexed citations

Lomer, Miranda, et al.. (2021). P328 Psychological need in patients with irritable bowel syndrome in secondary care. A210.2–A211.

Staudacher, Heidi M., Matthias Scholz, Miranda Lomer, et al.. (2020). Gut microbiota associations with diet in irritable bowel syndrome and the effect of low FODMAP diet and probiotics. Clinical Nutrition. 40(4). 1861–1870. 51 indexed citations

Wall, Catherine, Bridgette Wilson, Jeremy Sanderson, & Miranda Lomer. (2019). PTH-135 An inflammatory bowel disease-specific nutrition screening tool (IBD-NST) for better outpatient care. A102.2–A103. 1 indexed citations

10.

Lomer, Miranda, Gerassimos J. Mantzaris, Daniel R. Gaya, et al.. (2018). A multicentre Study of Nutrition Risk Assessment in Adult Patients with Inflammatory Bowel Disease Attending Outpatient Clinics. Annals of Nutrition and Metabolism. 74(1). 18–23. 17 indexed citations

11.

Rossi, Massimo, Gareth Parkes, Qasim Aziz, et al.. (2017). OC-026 Prebiotic b-galacto-oligosaccharides in conjunction with the low fodmap diet improves symptoms of irritable bowel syndrome but does not prevent decline of bifidobacteria: a randomised controlled trial. HighWire Press Open Archive. A14.1–A14. 1 indexed citations

12.

Staudacher, Heidi M., Peter M. Irving, Miranda Lomer, & Kevin Whelan. (2017). The challenges of control groups, placebos and blinding in clinical trials of dietary interventions. Proceedings of The Nutrition Society. 76(3). 203–212. 99 indexed citations

13.

McKenzie, Yvonne, et al.. (2016). British Dietetic Association systematic review of systematic reviews and evidence‐based practice guidelines for the use of probiotics in the management of irritable bowel syndrome in adults (2016 update). Journal of Human Nutrition and Dietetics. 29(5). 576–592. 51 indexed citations

14.

Martin, Lee, Cloete van Vuuren, Leah Seamark, et al.. (2015). OC-104 Long term effectiveness of short chain fermentable carbohydrate (FODMAP) restriction in patients with irritable bowel syndrome. Research Portal (King's College London). A51.2–A52. 4 indexed citations

15.

Joyce, Triona, Heidi M. Staudacher, Kevin Whelan, Peter M. Irving, & Miranda Lomer. (2014). PWE-092 Symptom Response Following Advice On A Diet Low In Short-chain Fermentable Carbohydrates (fodmaps) For Functional Bowel Symptoms In Patients With Ibd. Gut. 63(Suppl 1). A164.1–A164. 4 indexed citations

16.

Joyce, Triona, Heidi M. Staudacher, Kevin Whelan, Peter M. Irving, & Miranda Lomer. (2013). PTH-159 Group Education is as Effective as one-to-one Sessions when Administering the Low Fodmap Diet in Functional Bowel Disorders. Gut. 62(Suppl 1). A276.1–A276. 1 indexed citations

17.

Powell, Jonathan J., William B. Cook, Mark D. Chatfield, et al.. (2013). Iron status is inversely associated with dietary iron intakes in patients with inactive or mildly active inflammatory bowel disease. Nutrition & Metabolism. 10(1). 18–18. 7 indexed citations

18.

Staudacher, Heidi M., Miranda Lomer, John E. Anderson, et al.. (2012). Fermentable Carbohydrate Restriction Reduces Luminal Bifidobacteria and Gastrointestinal Symptoms in Patients with Irritable Bowel Syndrome. Journal of Nutrition. 142(8). 1510–1518. 435 indexed citations breakdown →

19.

Campbell, Helen, Michael Escudier, Pritash Patel, et al.. (2011). Distinguishing orofacial granulomatosis from crohn's disease: Two separate disease entities?. Inflammatory Bowel Diseases. 17(10). 2109–2115. 68 indexed citations

20.

Campbell, Helen, et al.. (2011). Review article: cinnamon- and benzoate-free diet as a primary treatment for orofacial granulomatosis. Alimentary Pharmacology & Therapeutics. 34(7). 687–701. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact